PAs and NPs of the Florida Keys

Expanding Evaluation and Referral of Anemia in Primary Care Settings to Diagnose Underlying Myelodysplastic Syndromes

CE Information
0.5 contact hours
Completion Time
30 minutes
Available Until
July 27, 2024
Posted By
Prime CE
Prime CE Prime CE
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.

Overview

Specialties
Family and Oncology
Subspecialties
Primary Care

Intended Audience: Primary Care Physicians, Hematologists/Oncologists, NPs, PAs, and Nurses

Primary care providers (PCPs) are uniquely positioned to be the first to observe anemia in adult patients during care visits. While anemia is a manifestation of an underlying disorder or deficiency, it is frequently overlooked, thereby underserving patients who may require treatment.

Tune in to this on-demand video, where an expert hematologist and PCP will discuss strategies for evaluating the underlying cause of anemia, interdisciplinary care coordination, and a review of the latest clinical evidence and guideline recommendations for myelodysplastic syndromes (MDS). Real-world data will be featured, providing insights into clinicians' biggest challenges in anemia evaluation and subsequent collaborative management of MDS.

Following the activity, download a concise guide to evaluation, referral, and coordination of care for patients with anemia.

Learning Objectives

  • Describe the role of primary care physicians in the evaluation, referral, coordination of care, and quality of life management for patients with anemia
  • Integrate interprofessional strategies for effective coordination of care for patients presenting with anemia to optimize treatment selection and outcomes
  • Identify factors associated with increased risk for lower-risk MDS
  • Evaluate clinical data on the safety and efficacy of current and emerging therapies for anemia-associated lower-risk MDS

Speakers

B Douglas Smith
B Douglas Smith MD

Professor of Oncology
Division of Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Baltimore, MD

Allan Platt
Allan Platt PA-C, MMSc, DFAAPA

Assistant Professor
Director of Admissions
Physician Assistant Program
Emory University School of Medicine

CE Information

This activity offers 0.5 contact hours to attendees.

Accredited by AANP.

Disclosures

*PRIME® has identified, reviewed, and mitigated all relevant financial relationships that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with ineligible companies to disclose:

  • B Douglas Smith, MD (Speaker)
    Consultant  AbbVie, Bristol-Myers Squibb, CSL-Behring, Novartis, Servier
    The relationships reported above are related to the following therapeutic area: Oncology

The following individuals have no relevant financial relationships with ineligible companies to disclose:

  • Allan Platt PA-C, MMSc, DFAAPA (Speaker)
  • Joyce M Knestrick, PhD, CRNP, FAANP (Reviewer)
  • Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP (Planner)
  • Annette Sophin, MSMM, PA-C (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with ineligible companies to disclose.


Ready to start this activity?

Login required. You will be redirected to an external website to register for and complete this activity.

Log in and start activity